FNY Investment Advisers, LLC
Position in BHC — Bausch Health Companies Inc.
CIK 1742998
NEW YORK, NY
Position in BHC
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$690
-$12 QoQ
Shares Held
140
+7.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#21
of 27 holders
Holding Since
Dec 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026FNY Investment Advisers, LLC holds $2,159,974 across 8 Drug Manufacturers - Specialty & Generic names. BHC ranks #7 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LQDA |
Liquidia Corp
|
17,500 | $1,395,275 | |
| 2 | ESPR |
Esperion Therapeutics, Inc.
|
110,000 | $347,600 | |
| 3 | HIMS |
Hims & Hers Health, Inc.
|
10,010 | $347,046 | |
| 4 | GLAS |
Glass House Brands Inc.
|
5,000 | $65,000 | |
| 5 | CRON |
Cronos Group Inc.
|
1,000 | $2,780 | |
| 6 | TLRY |
Tilray Brands, Inc.
|
300 | $1,347 | |
| 7 | BHC |
Bausch Health Companies Inc.
This page
|
140 | $690 | |
| 8 | AYTU |
Aytu Biopharma, Inc
|
110 | $236 |
All Filings in BHC
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $690 | 140 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $702 | 130 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | $208 | 30 | Shares | Sole | 2026-01-16 | |
| 2022-06-30 | $627 | 75 | Shares | Sole | 2022-07-12 | |
| 2022-03-31 | $2,285 | 100 | Shares | Sole | 2022-04-25 | |
| 2020-12-31 | $4,160 | 200 | Shares | Sole | 2021-01-19 | |
| No filing history on record for this holder in this stock. | ||||||